The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating ...

The pending deal was rumored overnight after a report from the Financial Times, spurring analysts to speculate that if true, ...

At the Heart in Diabetes CME Conference, speakers highlighted four recent reports published in the Journal of the American ...

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to US$1.3 billion to boost its pipeline beyond its blockbuster weight-loss and diabetes drugs.